Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

Trial Profile

Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Mar 2018

At a glance

  • Drugs Methylphenidate (Primary) ; Mixed amfetamine salts (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2018 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
    • 08 Mar 2018 Planned primary completion date changed from 1 Jul 2019 to 1 Jul 2020.
    • 08 Mar 2018 Planned initiation date changed from 1 Mar 2018 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top